REGENSBURG, Germany--(BUSINESS WIRE)--Transcatheter Technologies GmbH, an emerging medical device company that has developed a third-generation transapical transcatheter aortic valve implantation (TAVI) system—Trinity—announced today that it has expanded the Trinity technology platform to include a transfemoral version as well.
In September of this year, Transcatheter Technologies disclosed at the ‘TCT 2014’ scientific meeting the successful one-year follow-up results of its “truly repositionable” Trinity transapical TAVI system, designed to be the world’s best TAVI system. Unlike currently marketed TAVI systems, the Trinity aortic valve can be positioned precisely or even repositioned after full implantation in a safe manner. Equally important, Trinity’s unique sealing cuff continues to provide outstanding results without PVL, a well-known and frequent complication of TAVI. Furthermore, the risk of atrio-ventricular (AV) block has been essentially alleviated because of the supra-annular anchoring of the Trinity valve.
Help employers find you! Check out all the jobs and post your resume.
In September of this year, Transcatheter Technologies disclosed at the ‘TCT 2014’ scientific meeting the successful one-year follow-up results of its “truly repositionable” Trinity transapical TAVI system, designed to be the world’s best TAVI system. Unlike currently marketed TAVI systems, the Trinity aortic valve can be positioned precisely or even repositioned after full implantation in a safe manner. Equally important, Trinity’s unique sealing cuff continues to provide outstanding results without PVL, a well-known and frequent complication of TAVI. Furthermore, the risk of atrio-ventricular (AV) block has been essentially alleviated because of the supra-annular anchoring of the Trinity valve.
Help employers find you! Check out all the jobs and post your resume.